July 18, 2018July 18, 2018
CMT1A Patients Show Hearing Problems in Noisy Background, Study Reports
News
Patients with Charcot-Marie-Tooth type 1A (CMT1A) can have difficulty understanding speech in a noisy background, despite having a normal ... Read more
July 16, 2018July 12, 2018
Summer Is for Wearing Shorts
CMT and Me - a Column by Jill Price, Columns
“What did you do to yourself?” That was the first thing the saleswoman at the dress shop said to ... Read more
July 16, 2018July 16, 2018
$1M Awarded to Clinical Trial to Evaluate MRI in Assessing CMT Patients’ Muscle Changes
News
The Muscular Dystrophy Association (MDA) awarded more than $1 million to a new clinical trial (NCT03550300) to evaluate the ... Read more
July 13, 2018July 13, 2018
Multiple Ways Gene Now Linked to CMT Type 2, DHTKD1, Causes Disease Traced in Study
News
Mutations in DHTKD1, a recently discovered cause of a Charcot-Marie-Tooth (CMT) type 2 subtype, can lead to the disease through a ... Read more
July 11, 2018July 11, 2018
EMA Agrees to Pediatric Investigation Plan to Assess PXT30003 as a Treatment for Children with CMT1A
News
The European Medicines Agency has agreed to Pharnext SA’s pediatric investigation plan for PXT3003, an investigational therapy being developed to ... Read more
July 9, 2018July 9, 2018
When Communicating with Your Doctor, It’s Important to Detail All Symptoms for a Diagnosis
CMT and Me - a Column by Jill Price, Columns
Have you ever had a headache so severe that all you can do is stay in bed? The kind ... Read more
July 6, 2018July 6, 2018
Nerve Conduction Test May Help to Diagnose CMTX in People with Signs of CNS Involvement
News
A nerve conduction test may help to diagnose Charcot-Marie-Tooth disease type X (CMTX) patients with neurologic episodes more common to ... Read more
July 2, 2018June 28, 2018
Complicated Decisions to Make About My Hammertoe Surgery
CMT and Me - a Column by Jill Price, Columns
It was a busy week of doctor appointments — and decisions. First, I went to see my new orthotist. ... Read more
June 29, 2018June 29, 2018
Study Identifies the Ideal Tests to Improve Clinical Evaluation of CMT1A Patients
News
A new study has evaluated and identified the best tests to use as outcome measures, which help doctors track ... Read more
June 27, 2018June 27, 2018
Pharnext Shares Top-Line Results from Pivotal Phase 3 Studies of PXT3003; More to Come
News
Pharnext recently provided an update from its ongoing Phase 3 clinical trials evaluating PXT3003 for treating Charcot-Marie-Tooth disease type 1A ... Read more
June 25, 2018June 21, 2018
Summer Is a Time to Recharge
CMT and Me - a Column by Jill Price, Columns
Why is summer break so important? Because teaching is tough and exhausting. Throw in a physical disability like Charcot ... Read more
June 25, 2018June 25, 2018
Grünenthal Partners with Max Planck Society to Develop CMT Type 1A Treatments
News
Grünenthal, the Lead Discovery Center (LDC) and the Max-Planck Society have signed a research collaboration agreement to develop new ... Read more

July 18, 2018July 18, 2018

CMT1A Patients Show Hearing Problems in Noisy Background, Study Reports

News

Patients with Charcot-Marie-Tooth type 1A (CMT1A) can have difficulty understanding speech in a noisy background, despite having a normal hearing test, according to a study. The study, “Hidden hearing ... Read more

July 16, 2018July 12, 2018

Summer Is for Wearing Shorts

CMT and Me - a Column by Jill Price, Columns

“What did you do to yourself?” That was the first thing the saleswoman at the dress shop said to me before she even said hello. I was taken aback ... Read more

July 16, 2018July 16, 2018

$1M Awarded to Clinical Trial to Evaluate MRI in Assessing CMT Patients’ Muscle Changes

News

The Muscular Dystrophy Association (MDA) awarded more than $1 million to a new clinical trial (NCT03550300) to evaluate the potential of magnetic resonance imaging (MRI) in assessing muscle changes ... Read more

July 13, 2018July 13, 2018

Multiple Ways Gene Now Linked to CMT Type 2, DHTKD1, Causes Disease Traced in Study

News

Mutations in DHTKD1, a recently discovered cause of a Charcot-Marie-Tooth (CMT) type 2 subtype, can lead to the disease through a mechanism involving problems with cellular metabolism, insulin release, and overproduction ... Read more

July 11, 2018July 11, 2018

EMA Agrees to Pediatric Investigation Plan to Assess PXT30003 as a Treatment for Children with CMT1A

News

The European Medicines Agency has agreed to Pharnext SA’s pediatric investigation plan for PXT3003, an investigational therapy being developed to treat Charcot-Marie-Tooth disease type 1A (CMT1A). Because CMT1A typically appears ... Read more

July 9, 2018July 9, 2018

When Communicating with Your Doctor, It’s Important to Detail All Symptoms for a Diagnosis

CMT and Me - a Column by Jill Price, Columns

Have you ever had a headache so severe that all you can do is stay in bed? The kind in which every sound and bright light sends ripples of ... Read more

July 6, 2018July 6, 2018

Nerve Conduction Test May Help to Diagnose CMTX in People with Signs of CNS Involvement

News

A nerve conduction test may help to diagnose Charcot-Marie-Tooth disease type X (CMTX) patients with neurologic episodes more common to diseases of the central nervous system. The study, “The Electrophysiological ... Read more

July 2, 2018June 28, 2018

Complicated Decisions to Make About My Hammertoe Surgery

CMT and Me - a Column by Jill Price, Columns

It was a busy week of doctor appointments — and decisions. First, I went to see my new orthotist. I’m so glad I decided to speak up about how ... Read more

June 29, 2018June 29, 2018

Study Identifies the Ideal Tests to Improve Clinical Evaluation of CMT1A Patients

News

A new study has evaluated and identified the best tests to use as outcome measures, which help doctors track patient progress or deterioration, for those with Charcot-Marie-Tooth disease type ... Read more

June 27, 2018June 27, 2018

Pharnext Shares Top-Line Results from Pivotal Phase 3 Studies of PXT3003; More to Come

News

Pharnext recently provided an update from its ongoing Phase 3 clinical trials evaluating PXT3003 for treating Charcot-Marie-Tooth disease type 1A (CMT1A) in adults, and also announced that some top-line results ... Read more